Literature DB >> 14561909

Fractal analysis for quantitative evaluation of diffuse lung abnormalities on chest radiographs: use of sub-ROIs.

Shoji Kido1, Shinji Sasaki.   

Abstract

We evaluated the usefulness of fractal analysis for quantitative evaluation of diffuse lung abnormalities seen on chest radiographs. Regions of interest (ROIs) with 296 x 296 matrix size were selected in the right upper and lower lung zones of digitized chest radiographs. We selected ROIs of 50 mild and 50 severe diffuse lung abnormalities and 50 ROIs of normal lungs. The fractal dimension (FD) for each ROI was defined as the mean value of those obtained from sub-ROIs in each ROI. In the sub-ROIs with 256 x 256, 128 x 128, and 64 x 64 matrix size, the mean values of FDs obtained from the patients with diffuse lung abnormalities were significantly higher than those obtained from the patients with normal lungs (P < 0.001, respectively). The performance of FDs obtained from the sub-ROIs with 256 x 256 matrix size was equal to that obtained from the sub-ROIs with 128 x 128 matrix size (P = 0.980). However, the performance of FDs obtained from the sub-ROIs with 128 x 128 matrix size was superior to that obtained from the sub-ROIs with 64 x 64 matrix size (P = 0.0001). Fractal analysis is useful for quantitative evaluation of diffuse lung abnormalities seen on chest radiographs. From our results, the sub-ROIs whose matrix sizes were greater than or equal to 128 x 128 were suggested to be suitable for quantitative evaluation of diffuse lung abnormalities seen on chest radiographs.

Entities:  

Mesh:

Year:  2003        PMID: 14561909     DOI: 10.1097/00005382-200310000-00005

Source DB:  PubMed          Journal:  J Thorac Imaging        ISSN: 0883-5993            Impact factor:   3.000


  1 in total

1.  Automated measurement of heterogeneity in CT images of healthy and diseased rat lungs using variogram analysis of an octree decomposition.

Authors:  Richard E Jacob; James P Carson
Journal:  BMC Med Imaging       Date:  2014-01-06       Impact factor: 1.930

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.